Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.
about
Learning from marketing: Rapid development of medication messages that engage patientsPatients' knowledge and beliefs concerning gout and its treatment: a population based study.Access to oral osteoporosis drugs among female Medicare Part D beneficiaries.Why do women reject bisphosphonates for osteoporosis? A videographic study.Low acceptance of treatment in the elderly for the secondary prevention of osteoporotic fracture in the acute rehabilitation settingFactors associated with treatment of women with osteoporosis or osteopenia from a national survey.Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011Adherence and occurrence of fractures after switching to once-monthly oral bisphophonatesPatterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Bone quality: educational tools for patients, physicians, and educators.Reasons for not initiating osteoporosis therapy among a managed care population.Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysisGastrointestinal events and association with initiation of treatment for osteoporosis.Structural equation modeling of the proximal-distal continuum of adherence drivers.Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rulePatient-reported barriers to osteoporosis therapy.Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatmentEfficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.Overcoming problems with adherence to osteoporosis medication.Adherence with medications used to treat osteoporosis: behavioral insights.Management of osteoporosis of the oldest old.Self-perception of fracture risk: what can it tell us?Systematic scoping review of patients' perceived needs of health services for osteoporosis.The theory of planned behaviour explains intentions to use antiresorptive medication after a fragility fracture.Awareness of osteoporosis, risk and protective factors and own diagnostic status: a cross-sectional study.Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practicePrimary non-adherence to bisphosphonates in an integrated healthcare setting.Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™.Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.Evaluation of a Multi-modal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis: A Randomized Clinical Trial.Understanding patient compliance and persistence with osteoporosis therapy.A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.Factors related to intentional non-initiation of bisphosphonate treatment in patients with a high fracture risk in primary care: a qualitative study
P2860
Q27304575-2F235599-446D-47E8-9085-99069D21CEC1Q31096665-1EE6B1F7-D8D3-4184-A6FC-501B7EBEAB19Q33841382-7E9FFBE1-E004-4363-8D00-9CC803DD1EA8Q33886937-8A216F13-1046-44D3-97A0-BAF123AA65A0Q34055595-93EE70B3-A4FF-475E-B861-738CF74B15B2Q34120838-1D4AE006-AF51-4EE1-8C51-06A034977AA0Q34643685-66E1B8B2-D7E4-452C-944A-9E5DE05968F6Q34821660-E8F4169F-1E10-4F48-8D2A-BCCE8E72E35EQ35077750-55045A6A-D85C-4F9B-9EEB-0E4F2749991CQ35078751-B3FC8CE1-BFA7-491B-A368-970603B6D276Q35781017-356AB41F-3927-4435-B557-2DFA995D5FEEQ36006735-DA719B2A-18C8-444E-B650-A9F7C9967229Q36332223-8A639CB6-D092-4ED3-928B-BA72E74F438CQ36429615-CD0F5B75-5DB0-4197-807A-797C5B7F452DQ36830647-0E7D6C00-436E-4C3E-84B6-D0530ACA85D4Q36853473-CBB57D99-9D10-4A24-AC0F-F1B63D91AA0BQ37549106-CC47BB31-A79F-4C32-91F4-380406E4BEF9Q37768696-15183145-C9C0-48AE-800F-7F5FBBAA422CQ37820680-A86A4EAC-3D57-4A20-A6E5-2E41ADB4296DQ38075457-7F712D16-C733-44CD-906C-22F8A5E41B72Q38229503-B598C10B-325E-4A21-9045-8D52B98D9AA1Q38598416-F332F32C-80C5-4891-80EF-92ABCA98921AQ38650053-9B25D453-F192-4413-809E-FC0BCD3C79B4Q38831172-661675FC-1F99-412A-B155-4837EBF7823FQ39489917-638FEAA5-A40F-4713-A9E3-0EB9ACE82B92Q40959306-76446E09-1423-4CB5-B65F-A179E306A5D9Q41442835-2AC17FAF-222E-46DB-8D8B-3D9E33BF0241Q44164234-1119862F-8CCF-4F76-AB17-637B50EE46A2Q44485333-168AFCAC-B1FA-4D67-9EED-7D2DD76E9619Q46025463-9CE9C507-EBB5-412C-BBB6-0DD5A755A498Q48023761-68C7489C-6E5E-48E4-ACD5-50CD029745A0Q49609488-126DC7AF-ACDA-444A-BFFE-2867056BA825Q50629816-B29098E3-3919-46A6-BA81-A49CCBC473DEQ50922963-9C5F305E-DE6F-43BE-9C38-1E0933BB14FCQ58713667-8B080458-DC22-4CEB-A385-6229D4B4280B
P2860
Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Patient decision to initiate t ...... ence of knowledge and beliefs.
@en
type
label
Patient decision to initiate t ...... ence of knowledge and beliefs.
@en
prefLabel
Patient decision to initiate t ...... ence of knowledge and beliefs.
@en
P2093
P2860
P1476
Patient decision to initiate t ...... ence of knowledge and beliefs.
@en
P2093
Kathleen M Mazor
Kristijan H Kahler
Robert A Yood
Srinivas Emani
Susan E Andrade
P2860
P2888
P304
P356
10.1007/S11606-008-0772-0
P577
2008-09-12T00:00:00Z